Haleon is a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity.

Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. Haleon has a strong portfolio of brands and is well positioned to play a vital role for people all around the world, in a sector that is growing and more relevant than ever. We have nine Power Brands, which are supported by Local Growth Brands across the world.

Haleon has five brand categories, Oral Health, Vitamins, Minerals and Supplements (VMS), Pain, Respiratory, Digestive and Other. 

Haleon was established on 18 July 2022 as a corporate spin-off from GSK.

Haleon has a site in the commune of Prangins, part of the district of Nyon. The site currently employs 1,000 people in Prangins and produces 252 million units per year, including the medicines Voltaren and Otrivin.